Travel Vaccines Market

  • Published on 2025-11-10
  • Report Code: 678
  • 170-350 pages
Travel Vaccines Market

Travel Vaccines Market Segmented: By Composition (Mono Vaccines and Combination Vaccines); by Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others); by Application (Domestic Travel and Outbound Travel) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030

Table Of Content

Contents          

  1. Executive Summary
  2. Global Travel Vaccines Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Travel Vaccines Market Analysis
    1. Porters Five Forces
      1. Threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Travel Vaccines Market
    1. Market Size & forecast, 2020A-2030F
      1. By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12. Global Travel Vaccines Market: Market Segmentation
    1. By Regions
      1. North America:(the U.S. and Canada), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. the Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of the Middle East and Africa), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    2. By Composition: Market Share (2020-2030F)
      1. Mono Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Combination Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    3. By Disease: Market Share (2020-2030F)
      1. Hepatitis A, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. DPT, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      3. Yellow Fever, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      4. Typhoid, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      5. Hepatitis B, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      6. Measles and Mumps, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      7. Rabies, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      8. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
    4. By Application: Market Share (2020-2030F)
      1. Domestic Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
      2. Outbound Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  13. Company Profile

  14. GlaxoSmithKline Pharmaceuticals Limited
    1. Company Overview
    2. Company Total Revenue (Financials)
    3. Market Potential
    4. Global Presence
    5. Key Performance Indicators
    6. SWOT Analysis
    7. Product Launch
  15. Sanofi Pasteur
  16. Merck & Co., Inc.
  17. Novartis AG
  18. Pfizer Inc.
  19. ALK-Abelló A/S
  20. Bavarian Nordic A/S
  21. Crucell (Subsidiary of Johnson & Johnson)
  22. CSL Limited
  23. AstraZeneca PLC
  24. Altimmune, Inc.
  25. Abbott Laboratories
  26. Hoffmann-La Roche, Inc.
  27. Other Prominent Players

Consultant Recommendation

The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients